THE MOSS REPORTS
Last year, Dr. Allen Roses, a worldwide Vice President at GlaxoSmithKline
(GSK), Europe's largest drug company, gave an interview to the respected
British national newspaper, the Independent, in which he stated
that more than 90 percent of drugs only work in 30-50 percent of
people (Independent, Dec 8, 2003). To many in the alternative medicine
community, who have long been pointing out the ineffectiveness of
many standard medical interventions, Roses' statement was remarkable
as much for its source as for its content. For here was someone
from the highest echelons of the drug industry – and a high-ranking
academic scientist to boot (Dr. Roses is leading geneticist at Duke
University) – admitting that a staggeringly high proportion
of what is done in the name of medical science is known to be essentially
useless.
But how are patients to know what works and what does not? How
are people to make informed treatment choices if they cannot rely
on the efficacy of the treatments that are recommended to them by
their physicians?
For thirty years I have been studying and writing about cancer
and its treatment, sifting through the medical evidence, analyzing
the published data in order to ascertain what works and what does
not. The Moss Reports, a series
of more than two hundred separate reports on different types of
cancer and their treatment, represents the distillation of the knowledge
and insight I have acquired.
If you or your family are dealing with cancer, a Moss
Report can provide you with the key to understanding
the best that conventional and alternative medicine have to offer.
You can order a Moss Report
on your specific cancer type by calling Diane at
1-800-980-1234 (814-238-3367 from outside the US),
or by visiting our website: http://www.cancerdecisions.com
We look forward to helping you.
UPDATE ON DR. MICHAEL HOLICK
I never conceived of this newsletter as a political tool. My primary
aim has always been to educate patients and others who need current
and accurate information on cancer treatment and prevention. But
sometimes situations arise that require urgent action. Thus, several
weeks ago I brought to your attention the case of Michael Holick,
MD, PhD, a professor of dermatology at Boston University who was
fired for simply advocating a few minutes of sunlight exposure per
week. I offered you the chance of responding, with your own thoughts
in your own way, to Boston University's dermatology department.
The response has been heartening. First of all, over 1,000 of you
clicked on the link to Dr. William Grant's SUNARC website, which
explores the connection between a lack of sunlight exposure and
an increased risk of several diseases, including multiple sclerosis
(MS) and several types of cancer. Second, many of you wrote to Boston
University to complain about Dr. Holick's firing. We received copies
of 56 such letters, many of which were very eloquent, and this week
we are reprinting selected excerpts.
By the way, Dr. Holick's cause is not just fading away like last
month's suntan. On June 14, he received two pages of favorable coverage
in People magazine. The article began: "For Galileo, it was
that whole earth-goes-round-the-sun thing. Michael Holick's scientific
claim seems far less radical—he thinks getting a little sun
now and then is good for you." People magazine has a paid circulation
of 3.6 million and an overall readership more than ten times that.
And so Holick's message, and news of the outrageous treatment meted
out to him by his academic and professional colleagues, are now
coming to the attention of a broader audience. Prof. Holick was
recently in the United Kingdom promoting his new book, the UV Advantage,
and his work has been the focus of in-depth articles in the Guardian,
the BBC News, the Times of London, etc. Perhaps all this attention
will convince Boston University to reverse its intemperate decision.
YOUR THOUGHTS ON PROFESSOR HOLICK'S FORCED RESIGNATION
A large majority of those who sent us copies of letters they had
written expressed alarm at the trend toward political correctness
and the curtailment of academic freedom that was exemplified in
the way that Dr. Holick was treated by Boston University.
"I suggest that such a violation of Prof. Holick's academic
freedom is shocking and repugnant," wrote Dr. Donald D [Note:
Unless we have been specifically authorized to cite full names we
are only using people's first names and initials to protect their
privacy]. "I think it impugns your department's commitment
to intellectual honesty, and I hope your department will reconsider
its unwise action."
Dr. David M. wrote that this was "a reflection of an attitude
that can only hurt legitimate scientific discourse." He added:
"I am embarrassed as an alumnus of Boston University to see
this kind of dogmatic ruling against a legitimate researcher."
"Dr.Holick has been fired simply because he does not agree
with current sentiment," wrote Cheryl W. "This is hardly
scientific! A university should be a place where ideas can be freely
aired and discussed, not regulated."
Dr. Bill M. expressed similar sentiments: "Since the science
on this issue is mixed, reversing Boston University School of Medicine's
current position by reinstating Dr. Holick would be interpreted
by this writer as a rational action based on science, not on dogma
that is not well supported by the literature."
George R. also urged BU to reconsider its decision, and felt that
the firing of Dr. Holick was "an instance of institutional
suppression and punishment of researchers whose work challenges
generally accepted principles of clinical practice. While a healthy
dialogue about such subjects, and of course the revelation of the
funding sources and conflicts of interest of the author(s) are crucial
to the healthy progress of science, punishing those who have non-mainstream
opinions runs directly counter to the ethical standards...which
further scientific discovery and awareness."
Dr. Nan Fuchs, clinical nutritionist and editor of the Women's
Health Letter, agreed: "Your action is a sad commentary on
the state of education and the dissemination of information. I would
hope you are open enough to reconsider your decision," she
wrote.
Other correspondents drew on their own areas of professional expertise
in order to express their alarm. For example, David G. pointed out
that in negligence law there is a concept called 'res ipsa loquitur'
(a Latin phrase meaning 'the thing speaks for itself'), referring
to a situation in which there is no need to establish the cause
of a mishap that led to injury because that cause is self-evident.
"For instance," he writes, "my piano falls on your
head from my 4th floor apartment. No need to determine the cause
of your injuries. The piano did it and it belongs to me. A clear
case of res ipsa loquitur." He continues: "Dr. Holick's
forced resignation is a case of academic res ipsa loquitur. It is
perfectly obvious that Boston University has set the quest for truth
aside to pursue other goals. Whatever those goals are, they have
nothing to do with truth, science or respectable medical research."
Dr. Abram H., MD, one of the founders of orthomolecular medicine,
drew parallels with the case of Dr. Thomas Sydenham, a seventeenth-century
British physician who drew the ire of his medical contemporaries
by challenging the prevailing philosophy of smallpox treatment,
yet who is now recognized and revered as the father of clinical
bedside medicine. "I thought that today surely we are much
more enlightened than our former colleagues were and that we are
prepared to reason with evidence even if it goes against the old
paradigm," writes Dr. H. Not only is this an issue of academic
freedom of speech, he continues, but also one of urgent clinical
importance since the deliberate avoidance of sunlight is contributing
to an alarming increase in overt vitamin D deficiency, one of the
consequences of which is the development of the crippling bone disease
rickets. "In Canada," Dr. H. writes, "pediatricians
are being warned to deal with the increase in rickets following
the advice of the dermatologists. Until now rickets was extremely
rare."
Several others were also reminded of historical precedents for
the hounding of scientific mavericks. "Looking back over the
vast history of all scientific research and knowledge," wrote
Karen McI., "major breakthroughs have often come after much
persecution of those who proffer an opposing view." If what
[Dr Holick] advocates has no merit, it will quietly fail on its
own. But if it indeed has merit that is eventually proven, then
your [Boston University's] criticism will come back to haunt you."
Dr. Andrea Z. expressed a similar sentiment. She urged BU to "[p]lease
immediately rehire Dr Holick. Members of the scientific community
must be able to hold varying opinions. Saying that the sun is bad
is like saying the earth is flat... Old beliefs must be re-examined
via research and debate."
The entrenched resistance to change exemplified by BU's decision
also alarmed Jocelyn P-A, who wrote: "I am absolutely shocked
that Boston Medical would fire a physician, Dr Holick, whose ideas
and research do not mirror the paradigm of thinking within the institution.
How else are advances in medicine ever made but when dogma...is
challenged?"
Janine Z. put it succinctly: "The forced resignation of Dr.
Holick for his intelligent scientific vision is just another example
of medical dogma passing for science."
Another correspondent, Terry T., felt that Dr Holick might actually
be better off out of BU: "Any reasonably literate person can
see that Dr. Holick was fired as a result of a agenda-driven political
position having absolutely nothing do with science, nothing to do
with ethics, and certainly nothing to do with contributing to the
open dialogues that are essential to research. I presume Dr. Holick
will survive and prosper, having been relieved of the daily drudgery
of forced interaction with such disagreeable and unethical associates."
Others were acutely aware, on a personal level, of the inhibiting
effect that Dr Holick's firing may have on clinical research as
a whole. Glenn N., himself a cancer survivor, expressed the view
that BU's attempt "to strangulate a certain direction of medical
research is unethical and is directly harming me and other cancer
patients who need all the help we can get. Please reinstate Dr.
Holick and allow him to continue his research, which could potentially
save lives, including mine."
Another correspondent, Michael G., a clinical pharmacist who works
primarily with geriatric patients, drew attention to the fact that
a recent meta-analysis published in the April, 2004, issue of the
Journal of the American Medical Association (JAMA) found
that taking vitamin D supplements reduced the risk of falls in older
people. Falls are the largest single cause of death from injury
in older people and account for 40 percent of all nursing home admissions.
Costs from fall-related injuries are projected to increase to 32.4
billion dollars by the year 2020. Michael G. continues: "Recent
research has found that the incidence of such falls is increased
in nursing home populations due to low vitamin D levels (possibly
at least in part because of a lack of sun exposure). This is one
more reason that a dogmatic approach to sun exposure is premature
and based on insufficient information. I ask you to reconsider your
actions against Dr. Holick."
People Who Live in Glass Houses...
Some correspondents were stung by the apparent double standard implicit
in criticizing Dr. Holick for the research support he has received
from the indoor tanning industry, when medical research at every
level is financed and supported by the pharmaceutical industry.
"Those who object to Dr. Holick's connections to indoor tanning
should open their eyes to the fact that without funds there can
be no research," wrote June R. "I would ask the Department
of Dermatology if the funding of research from the chemical sunscreen
industry should also be prohibited?" And, as Ed M. pointed
out: "It is becoming clearer every day that allopathic medicine
is bought and paid for by the pharmaceutical companies. If allopathic
medicine and its total orientation to 'legalized' drug use - at
the expense of 106,000 deaths per year by adverse drug reactions
- were really healing people, the population wouldn't be running
so fast to seek alternatives." (Note: see reference to Lazarou,
1998, below.)
Susan C. expressed the hope that one day this kind of corrupting,
destructive association between industry and research will be a
thing of the past. "I can only hope that the intellectual and
scientific myopia engendered by these collaborations with industry
among the major research institutions will give way to a greater
curiosity about the many differing possibilities for the treatment
of human disease and suffering," she wrote.
Just What the Doctor Ordered
Two more readers, both physicians, felt that the Holick firing raised
important questions concerning the nature of medical practice. William
L., MD, himself a cancer survivor, pointed out that the actions
of the dermatology community in demonizing sunshine arise from a
misguided and simplistic attempt to pinpoint a single cause for
skin cancer. "We must feel some empathy for the poor dermatologists,
whose approach to medicine is indeed 'superficial,' and who for
the most part fail to realize that the skin disorders they attempt
to treat are more than skin deep."
Dr. Sean M. wrote "I make a point of getting full body exposure
to sunlight every day for a brief period in order to promote vitamin
D synthesis. The hype over sun block lotions is just another example
of the power of advertising in our lives today; not good science,
just hysteria."
The patient's perspective was well put by Debi S., who wrote: "Are
we not continually revising medical 'facts'? I would rather have
a doctor like Dr. Holick who thinks for himself instead of just
trusting as gospel the current ideas on medicine. There is still
too much we don't know about human physiology to dismiss new concepts.
To do so is a grave disservice not only to us, but to future generations.
We need 'out-of-box' thinkers like Dr. Holick to challenge the accepted."
The Last Word
The last word goes to Allen K., of Temecula, CA, who summed up the
sentiments of many when he wrote: "I once heard Dr. John R.
Lee say, 'When you hear reports that 99 out of 100 doctors believe
in a specific idea, I always ask myself, what does that one doctor
know that the other 99 don't know?' Without the right of dissent,
how is medicine to advance? I don't think it was appropriate to
fire Dr. Holick for what really amounts to a very moderate deviation
from that of orthodox dermatology."
I want to thank all of you for taking the time to express your
feelings on this issue with such eloquence. There were dozens more
messages, but the constraints of space prevent me from printing
them all. I am sure that your letters will cause Boston University
officials to think long and hard about the consequences of forcing
Dr. Holick's resignation.
--Ralph W. Moss, Ph.D.

References:
Dr. Allen Roses interview reported in British
Medical Journal:
http://bmj.bmjjournals.com/cgi/content/full/bmj;327/7428/1366
(Full text of interview can be purchased from
The Independent:
http://news.independent.co.uk/low_res/story.jsp?story=471139&host=3&dir=505
)
Lazarou J, Pomeranz BH, Corey PN.
Incidence of adverse drug reactions in hospitalized patients: a
meta-analysis of prospective studies. JAMA. 1998 Apr 15;279(15):1200-5).
Dr. William Grant SUNARC Foundation
– http://www.sunarc.org
**NOTE**
To view this page in a more
printable format, please CLICK
HERE.
IMPORTANT DISCLAIMER
The news and other items in this newsletter
are intended for informational purposes only. Nothing in this newsletter
is intended to be a substitute for professional medical advice.
 |
|
CancerDecisions®
PO Box 1076, Lemont, PA 16851
Phone Toll Free: 800-980-1234 | Fax: 814-238-5865
Copyright
© 1996-2003 All Rights Reserved |
|
|